會議專家簡介：管忠震教授
Guan Zhongzhen , male, Born in Oct. 1932 at Anhui China. Education: MD Lingnan Univ. Medical School, 1954. Post-doctoral Training on Hematology, Chinese Acad Med. Scis Hematology Inst. 1963; WHO Sponsored Visiting Scholar, M.D. Anderson Hosp & Res Inst, Houston, and was appointed as visiting Assoc Prof, 1982~1983. Appointments: Director of Cancer Hospital, Sun Yat-sen Medical Univ. Guangzhou (1986~1993). Prof & Chief, Medical Oncology Dept. Member of Directors, Chinese National Board of Cancer Management & Research. Chairman, Oncology/Hematology Drug Evaluation Committee, Chinese Ministry of Health. Dir, Chinese Anticancer Assoc & President of Canton Branch. Also：Member of scientific advisory board , IOF; Scientific advisor of cancer Institute, Chinese Univ of Hong Kong. Main interest of Study: Chemotherapy of Lymphomas, Lung Cancer, Breast Cancer, and new anticancer drug development. Contributions to: Chinese J. Intern. Med; Chinese J. of Cancer, J of Res & Clin Oncology; Int J Clin Pharm Res.etc.
P.I of many domestic and imported anticancer drugs including Vinorebin, Vindesine,THP-Doxorubicin, Ifosfamide, Lobaplatin,Nedaplatin,Gemcitabine,Docetaxel,10-Hydroxy-Camptothecin,Irinotecan,Oxaliplatin,Topotecan,Gefitinib etc. Also participating many international multicentric studies including HERA trial, Gemzar in Liver Cancer, Topotecan for 2nd line NSCLC. Topotecan /DDP vs Etoposide/DDP in 1st line SCLC, Gefetinib in Chinese pts of NSCLC, IPASS study, Lapatinib in Breast Ca including 1st line HER2 (+) pts and ALLTO trial, TEACH trial, Sorafenib in HCC, etc.
Dr GUAN is one of the pioneers of medical oncology in China. He was recipient of distinguished teachership from the Guangdong Provincial government and also award from Sun Yat-sen University, ACOS and Chinese Anticancer Association.
編輯: ludongcn 作者:丁香園通訊員
以下網友留言只代表網友個人觀點，不代表網站觀點
